Synthesis and Antitumor Activity of Aza-Brazilan Derivatives Containing Imidazolium Salt Pharmacophores

Mingqin Huang,Shengzu Duan,Xueqiong Ma,Bicheng Cai,Dongmei Wu,Yan Li,Liang Li,Hongbin Zhang,Xiaodong Yang
DOI: https://doi.org/10.1039/c9md00112c
2019-01-01
MedChemComm
Abstract:The synthesis of a series of novel aza-brazilan derivatives containing imidazolium salt pharmacophores is presented. The biological activity of such imidazolium salts was further evaluated in vitro against a panel of human tumor cell lines. The results suggest that the electron-withdrawing group on the aza-brazilan moiety, substituted 5,6-dimethyl-benzimidazole ring and substitution of the imidazolyl-3-position with a 4-methylbenzyl group were essential for modulating the cytotoxic activity. Compounds 55 and 39, bearing a 4-methylbenzyl substituent at position-3 of 5,6-dimethyl-benzimidazole, were found to be the most potent compounds with IC50 values of 0.52-1.30 μM and 0.56-1.51 μM against four human tumor cell lines investigated. Particularly, compound 57 exhibited inhibitory activity against the MCF-7 cell line with an IC50 value of 0.35 μM and was 56-fold more sensitive than DDP. Moreover, compound 55 inhibited cell proliferation through inducing G0/G1 cell cycle arrest and apoptosis in SMMC-7721 cells.
What problem does this paper attempt to address?